Development and Validation of a High-Performance Liquid Chromatography–Tandem Mass Spectrometry Method for the Simultaneous Determination of Irinotecan and Its Main Metabolites in Human Plasma and Its Application in a Clinical Pharmacokinetic Study-Reference-Cited by-同舟云学术

Development and Validation of a High-Performance Liquid Chromatography–Tandem Mass Spectrometry Method for the Simultaneous Determination of Irinotecan and Its Main Metabolites in Human Plasma and Its Application in a Clinical Pharmacokinetic Study

Published:2015-02-17 Issue:2 Volume:10 Page:e0118194
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Marangon Elena,Posocco Bianca,Mazzega Elisa,Toffoli Giuseppe

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference15 articles.

1. Review of biomarkers in colorectal cancer;KF Newton;Colorectal Dis,2012

2. Pharmacogenomic testing in current clinical practice: implementation in the clinical laboratory;AHB Wu,2011

3. Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer;G Toffoli;J Clin Oncol,2010

4. Association between UGT1A1*28 Polymorphisms and Clinical Outcomes of Irinotecan-Based Chemotherapies in Colorectal Cancer: A Meta-Analysis in Caucasians;X Liu;PLoS One,2013

5. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan;F Innocenti;J Clin Oncol,2004

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of anti-SN38 antibody for loading efficacy and therapeutic monitoring of SN38-containing therapeutics;Heliyon;2024-06

2. A validated high‐performance liquid chromatography‐tandem mass spectrometry method for simultaneous determination of irinotecan and two major metabolites in rat plasma: Application for the pharmacokinetics study;SEPARATION SCIENCE PLUS;2024-05-10

3. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update;Journal of Chromatography B;2024-04

4. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis;Journal of Chromatography B;2024-02

5. IRINOTECAN-REVIEW OF ANALYTICAL METHODS DEVELOPED FOR PHARMACEUTICAL DOSAGE FORMS AND BIOLOGICAL FLUIDS;International Journal of Applied Pharmaceutics;2023-11-07